• Return to Headlines

Regeneron Pharm Has Returned 24.3% Since SmarTrend Recommendation (REGN)

By Amy Schwartz

SmarTrend identified a Downtrend for Regeneron Pharm (NASDAQ:REGN) on March 8th, 2019 at $403.54. In approximately 3 months, Regeneron Pharm has returned 24.25% as of today's recent price of $305.67.

Regeneron Pharm share prices have moved between a 52-week high of $445.00 and a 52-week low of $281.89 and are now trading 8% above that low price at $305.67 per share. The 200-day and 50-day moving averages have moved 0.38% lower and 2.43% lower over the past week, respectively.

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Regeneron Pharm.

Log in and add Regeneron Pharm (REGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights regeneron pharm

Ticker(s): REGN